{"id":69926,"date":"2025-11-14T08:42:21","date_gmt":"2025-11-14T08:42:21","guid":{"rendered":"https:\/\/psychologydictionary.ae\/initiative-de-neuroimagerie-pour-alzheimer\/"},"modified":"2025-11-14T08:42:21","modified_gmt":"2025-11-14T08:42:21","slug":"initiative-de-neuroimagerie-pour-alzheimer","status":"publish","type":"post","link":"https:\/\/psychologydictionary.ae\/fr\/initiative-de-neuroimagerie-pour-alzheimer\/","title":{"rendered":"Initiative de neuroimagerie pour Alzheimer"},"content":{"rendered":"<p>Une \u00e9tude \u00e0 grande \u00e9chelle visant \u00e0 collecter et analyser des donn\u00e9es sur la neuroimagerie, la g\u00e9n\u00e9tique, les biomarqueurs et la fonction cognitive chez des patients atteints de la maladie d\u2019Alzheimer et d\u2019autres troubles de la m\u00e9moire. L\u2019objectif de l\u2019ADNI est de mieux comprendre les m\u00e9canismes de progression de la maladie d\u2019Alzheimer et de d\u00e9velopper des m\u00e9thodes de diagnostic pr\u00e9coce, ainsi que de cr\u00e9er des outils pour \u00e9valuer l\u2019efficacit\u00e9 du traitement. Utilise diverses technologies de neuroimagerie, telles que l\u2019IRM, la PET et d\u2019autres techniques, pour surveiller les changements c\u00e9r\u00e9braux pouvant \u00eatre associ\u00e9s au d\u00e9veloppement de la maladie d\u2019Alzheimer. De plus, le projet collecte des donn\u00e9es g\u00e9n\u00e9tiques et biochimiques qui aident les chercheurs \u00e0 identifier les biomarqueurs possibles de la maladie. L\u2019\u00e9tude constitue une ressource importante pour les scientifiques, cliniciens et entreprises pharmaceutiques \u0153uvrant dans le domaine de la d\u00e9mence et des maladies neurod\u00e9g\u00e9n\u00e9ratives, et contribue \u00e0 acc\u00e9l\u00e9rer la recherche de nouvelles m\u00e9thodes pour diagnostiquer et traiter la maladie d\u2019Alzheimer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une \u00e9tude \u00e0 grande \u00e9chelle visant \u00e0 collecter et analyser des donn\u00e9es sur la neuroimagerie, la g\u00e9n\u00e9tique, les biomarqueurs et la fonction cognitive chez des patients atteints de la maladie d\u2019Alzheimer et d\u2019autres troubles de la m\u00e9moire. L\u2019objectif de l\u2019ADNI est de mieux comprendre les m\u00e9canismes de progression de la maladie d\u2019Alzheimer et de d\u00e9velopper [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[218],"tags":[],"class_list":["post-69926","post","type-post","status-publish","format-standard","hentry","category-concepts-psychologiques-cles-en-neuropsychologie-clinique"],"_links":{"self":[{"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/posts\/69926","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/comments?post=69926"}],"version-history":[{"count":0,"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/posts\/69926\/revisions"}],"wp:attachment":[{"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/media?parent=69926"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/categories?post=69926"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychologydictionary.ae\/fr\/wp-json\/wp\/v2\/tags?post=69926"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}